CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Open-market buy Chief Executive Officer bought 30,000 shares at $3.22 ($96,600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President, COO & CFO acquired 1,117 shares (grant or award)
- 4 Option exercise Director acquired 16,000 shares (option exercise)
- 4 Option exercise Director acquired 120,000 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 11,800 shares at $3.57 ($42,126)
- 4 Open-market buy President, COO & CFO bought 5,500 shares at $3.64 ($20,020)
- 4 Grant or award President, COO & CFO acquired 865 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition President, COO & CFO acquired 1,069 shares (other)
- 4 Option exercise Director acquired 40,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 491,900 shares (to pay taxes)
Page 4 of 24 · 471 filings